Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 179

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

Metabolic dysfunction and alcohol-related liver disease (MetALD): Position statement by an expert panel on alcohol-related liver disease

Open access
Arab, Juan Pablo, Díaz, Luis Antonio, Rehm, Jürgen, Im, Gene, Arrese, Marco, Kamath, Patrick S., Lucey, Michael R., Mellinger, Jessica, Thiele, Maja, Thursz, Mark, Bataller, Ramon, Burton, Robyn, Chokshi, Shilpa, Francque, Sven M., Krag, Aleksander, Lackner, Carolin, Lee, Brian P., Liangpunsakul, Suthat, MacClain, Craig, Mandrekar, Pranoti, Mitchell, Mack C., Morgan, Marsha Y., Morgan, Timothy R., Pose, Elisa, Shah, Vijay H., Shawcross, Debbie, Sheron, Nick, Singal, Ashwani K., Stefanescu, Horia, Terrault, Norah, Trépo, Eric, Moreno, Christophe, Louvet, Alexandre, Mathurin, Philippe · 2025 · Journal of Hepatology

Abstract

Summary In this position statement, we explore the intricate relationship between alcohol intake and metabolic dysfunction in the context of the 2023 nomenclature update for steatotic liver disease (SLD). Recent and lifetime alcohol use should be accurately assessed in all patients with SLD to facilitate classification of alcohol use in grams of alcohol per week. Alcohol biomarkers (i.e., phosphatidylethanol), use of validated questionnaires (i.e. AUDIT-C [alcohol use disorders identification test consumption]), and collateral information from friends and relatives could help facilitate differentiation between alcohol-related liver disease (ALD) per se and liver disease with both metabolic and alcohol-related components (MetALD). Heavy alcohol use can contribute to cardiometabolic risk factors such as high blood pressure, hypertriglyceridaemia, and hyperglycaemia. As a result, caution should be exercised in the application of only one metabolic dysfunction criterion to diagnose MASLD, as suggested in the 2023 nomenclature document, particularly in individuals exceeding weekly alcohol use thresholds of 140 g for women and 210 g for men. This is particularly important in those individuals with isolated high blood pressure, hypertriglyceridaemia, or hyperglycaemia, where the disease process may be driven by alcohol itself. Additionally, metabolic dysfunction and alcohol use should be reassessed over time, especially after periods of change in risk factor exposure. This approach could ensure a more accurate prognosis and effective management of SLD, addressing both metabolic and alcohol-related factors.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jhep.2024.11.028

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 27 references

Cited by

See all 179

Metadata

Authors
Arab, J. P., Díaz, L. A., Rehm, J., Im, G., Arrese, M., Kamath, P. S., Lucey, M. R., Mellinger, J., Thiele, M., Thursz, M., Bataller, R., Burton, R., Chokshi, S., Francque, S. M., Krag, A., Lackner, C., Lee, B. P., Liangpunsakul, S., MacClain, C., Mandrekar, P., Mitchell, M. C., Morgan, M. Y., Morgan, T. R., Pose, E., Shah, V. H., Shawcross, D., Sheron, N., Singal, A. K., Stefanescu, H., Terrault, N., Trépo, E., Moreno, C., Louvet, A., & Mathurin, P.
Venue
Journal of Hepatology
Publisher
Elsevier BV
Published
2025-04
Volume
82
Issue
4
Pages
744-756
ISSN
0168-8278 (ISSN-L)
OpenAlex
W4404771310
Cited by
179
References
27
FWCI
46.80
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Metabolic dysfunction and alcohol-related liver disease (MetALD): Position statement by an expert panel on alcohol-related liver disease. https://app.cochat.ai/papers/10.1016/j.jhep.2024.11.028
The paper
Arab, J. P., Díaz, L. A., Rehm, J., Im, G., Arrese, M., Kamath, P. S., Lucey, M. R., Mellinger, J., Thiele, M., Thursz, M., Bataller, R., Burton, R., Chokshi, S., Francque, S. M., Krag, A., Lackner, C., Lee, B. P., Liangpunsakul, S., MacClain, C., . . . Mathurin, P. (2025). Metabolic dysfunction and alcohol-related liver disease (MetALD): Position statement by an expert panel on alcohol-related liver disease. Journal of Hepatology. https://doi.org/10.1016/j.jhep.2024.11.028

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.